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bstract
Plants with potential therapeutic values have been used from time immemorial to cure various ailments and infectious diseases. Of late, scientific
vidences have been provided on the potential therapeutic agent exhibited by certain traditionally used vegetable extracts. The importance of
ild edible plants may be traced to antiquity but systemic studies are recent. All the Momordica  species have been consumed as vegetable and
raditionally used for various disorders. The whole plant parts are ascribed to possess the anti-diabetic effect in traditional medicinal system. The
ctive constituents of Momordica  plant parts were cucurbitane type triterpenoids, phenolics, glycosides, and several kinds of peptides including
omordica  anti-HIV protein (MAP 30). Recent reports revealed the presence of several kinds of cucurbitane type triterpenoids in leaf, stem and
ruits of Momordica  species having several pharmacological activities. There is lack of scientific information available on the wild species which
lso having several bioactive components with potential activities. So the present review compares and highlights the current knowledge of the
utritional value, phytochemistry and physiological effects of wild species with known variety.
 2014 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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t.  Introduction
Momordica  species are vegetable crops, belonging to the
amily of Cucurbitaceae (also commonly referred as cucumber,
ourd, melon or pumpkin family), which comprise of medium
ized plants that grow abundantly in warmer regions of the world.
hey are well-known for the bitter taste due to the presence
f phytochemicals (alkaloid) and have a wide range of medic-
nal values. Although the exact origin of Momordica  genus
s unclear, most experts agree that the center of bitter gourd
omestication lies in eastern Asia, possibly eastern India or
outhern China [1,2]. However, in Ayurvedic texts written by
embers of the Indo-Aryan culture, it is stated to be emerged in
ndia from 2000 to 200 BCE [3]. Consumption of Momordica
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ttp://dx.doi.org/10.1016/j.fshw.2014.07.001pecies as vegetables is mainly concentrated in Africa and Asian
ountries. The fruits are usually parboiled or soaked in salt water
efore cooking to reduce the bitter taste [4]. The Momordica
pecies have been used in indigenous medical systems in various
ountries in Asia and Africa. Based on the indigenous knowl-
dge, wild plant foods play a vital role in the complex cultural
ystem of tribal people for reducing various disorders. Research
as shown that many edible wild plants are rich in specific con-
tituents, referred as phytochemicals, which may have health
romoting effects. The major plant-derived chemical groups in
his family now recognized as having potential health promoting
ffects in Type I and Type II diabetes are cucurbitane triter-
enoids, saponin glycosides and Momordica  anti-HIV protein
MAP 30 protein). These phytochemicals may be incorporated
nto food stuffs or food supplements as nutraceuticals. The green
ruits and leaves of Momordica  species play a major role in
mproving human health by offering nutritional and nutraceu-
ical components. Therefore the present review mainly focuses
n providing baseline information on exploring nutritional and
utraceutical properties of some wild plant species along with
ultivated variety of Momordica  species such as M.  charan-
ia, M.  balsamina  (Linn), M.  dioica  (Roxb), M.  cochinchinensis
lsevier B.V. All rights reserved.
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iFig. 1. Green fruits of d
Spreng), and M.  tuberosa  or cymbalaria. Fig. 1 shows the green
ruits of five different species in this genus. This study highlights
he potential of Momordica  species as an important source of
oth nutritional and bioactive compounds. In addition, this study
lso supports the inclusion of these wild species into the main
ood stream of the local population, improving their nutritional
tatus..  Biogeography  and  botanical  description
Based on both historical literature [1,2,5], and recent anal-
sis of random amplified polymorphic DNA [6], inter simple
A
e
znt Momordica species.
equence repeats [7] and amplified fragment length polymor-
hisms [8] molecular analyses, eastern India (including the
tates of Orissa, West Bengal, Assam, Jharkhand and Bihar)
ay be considered as the primary center of the diversity of
itter gourd, where a wild feral form, M. charantia  varieties
lso exists. M.  dioica  and M.  charantia  are ubiquitous in dis-
ribution over India except in north-east region, whereas M.
ubangulata  ssp. Renigera  is restricted to north-east and adjoin-
ng north Bengal hills. M.  cochinchinensis  is distributed in
ndaman and a few of regions in the eastern and north east-
rn states of India. M.  balsamina  is restricted to the arid belt
ones such as Rajasthan and Gujarat, while M.  cymbalaria  is
G. Nagarani et al. / Food Science and Human Wellness 3 (2014) 117–126 119
Table 1
Proximate and mineral composition of Momordica fruit.
Compositions M. charantia M. dioica M. balsamina M. cymbalaria M.  cochinchinesis
Moisture/% 93.20 84.1 71.00 84.30 88.6
Ash/% 7.36 6.7 18.00 – –
Lipids/% 6.11 4.7 2.66 – 0.1
Fiber/% 13.60 21.3 29.00 6.42 1.1
Protein/% 27.88 19.38 11.29 2.15 1.5
Carbohydrate/% 34.31 47.92 39.05 12.60 7.6
Energy kcal/100 g 241.66 311.5 189.22 73.00 37.0
Calcium mg/100 g 20 33 941 72.00 64.0
Magnesium mg/100 g – – 220 – –
Sodium mg/100 g 2.40 1.51 122.49 40.00 –
Potassium mg/100 g 171.00 8.25 1320.00 500.00 –
Iron mg/100 g 1.8 4.6 60.3 1.70 0.34
Zinc mg/100 g – – 3.18 2.82 –
Manganese mg/100 g 0.08 – 11.6 0.32 –
Copper mg/100 g 0.19 – 5.44 0.18 –
Phosphorus mg/100 g 70 42 130.46 0.46 89.0
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ehera et al. [4]; Hassan and Umar [11].
istributed in Andhra Pradesh, Karnataka, Madhya Pradesh and
aharashtra. M.  sahyadrica  is a recently described species [9]
nd is endemic to the Western Ghats of India. In general, these
lants are commonly annuals or perennials. Leaves are entire
r deeply lobed (3–7). Flowers are monoecious or dioecious,
olitary/pseudo raceme, medium to big size, with foliaceous
racts, corolla creamish yellow to bright yellow color, green
o pale green stigma (in monoecious species) or yellow (in dioe-
ious species). Fruits are medium to big sized (5–800 g), fleshy,
reen when unripe and orange red when ripe, ovoid oblon-
oid, ornamented with soft spines, warts or tubercles, splits
rom base into three valves. Seeds are enclosed in orange red
v
a
m
m
able 2
omparative account of amino acid composition of Momordica species with WHO a
mino acid M. charantia fruitsa (mg/g) M. bal
ystine 22.3 5.6 
spartic acid 93.8 82.1 
hreonine 25.2 31.3 
erine 55.0 40.0 
lutamic acid 96.0 123.8 
roline 54.4 32.1 
lycine 44.9 46.6 
lanine 51.2 41.6 
aline 42.2 41.1 
soleucine 30.8 – 
eucine 64.9 83.8 
yrosine 59.4 26.2 
henylalanine 40.2 39.4 
ethione 27.6 9 
istidine 72.8 25.0 
ysine 101 39.4 
rginine 45.6 48.7 
ryptophan – – 
ote:
a M. charantia fruit mature pericarp.
b M. balsamina leaves.
c Mean nitrogen requirement of 105 mg nitrogen/kg per day (0.66 g protein/kg per 
orax et al. [84]; Hassan and Umar [11]; WHO/FAO/UNU [85].– 290 0.04
arcotesta (aril), and sculptured, margins often undulate and
entate [10].
.  Nutritional  values
The mature green fruit of the Momordica  species is the most
ommonly consumed portion of the plant, although the tender
eaves of M.  balsamina  can be cooked as a leafy vegetable pro-
iding an important source of nutrients [11]. These green fruits
nd leaves are a good source of carbohydrates, proteins, vita-
ins and minerals (Table 1). The protein content of this species
akes it a good source of essential amino acids (Table 2) such
dult requirements.
samina leavesb (mg/g) Amino acid content meeting FAO
recommendations (mg/g protein)c
4
–
23
–
–
–
–
–
39
30
59
38
38
16
15
45
–
6
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s methionine, phenylalanine, alanine, serine, cystine and thre-
nine compared to other vegetables and traditional protein-rich
egumes [4]. Differences in the agro-climatic conditions may
ccount for the variation in the protein contents in this species.
assan and Umar [11] have studied the nutritional values of M.
alsamina  leaves. In comparison with other species, M.  balsam-
na leaves have more dietary fiber (29%) and mineral contents
Table 1) while Momordica  fruits have moderate content of
ietary fiber, which helps to lower the blood cholesterol. M.
alsamina leaves are labeled as a heart protective leafy veg-
table because of its high content of potassium (1320 mg/100 g)
hat helps to maintain normal blood pressure and other cardio-
ascular conditions [12]. The trace element, zinc, has also been
eported in fruits and leaves of Momordica  species (Table 1).
.  Bioactive  compounds
Momordica  plant parts are characterized by a wide diver-
ity of bioactive compounds such as phenolic acids, flavonoids,
arotenoids cucurbitane triterpenoids, and phytosterols. The
otential health benefits of phytochemicals found in Momordica
pecies have received ample attention in the recent literature,
ocusing especially on compounds with high antidiabetic, antitu-
or and antioxidant properties. In particular, some of the actual
rends of the scientific research are strongly focused on obtaining
n vitro  evidence for the biological efficacy of individual con-
tituents such as triterpenoids, carotenoids and phenolics from
ifferent parts of Momordica  spp. Around 228 different com-
ounds were identified from different parts of M.  charantia  [13].
owever, with regard to these various bioactive substances of
. charantia, only limited information was found on the wild
pecies due to limited habitat and lack of awareness.
.1.  Phenolics  compounds
Phenolic compounds are chemical substances considered as
ajor secondary metabolites of plant origin having more than
ne phenol group per molecule. Phenolics are classified into two
ategories as flavonoids and non flavonoids. Flavonoids share a
asic structure consisting of two benzene ring linked through a
w
a
fl
able 3
henolic acid composition of different parts with different maturity level of M. cochi
ruit fractions Hydroxybenzoic acids (mg/g) Hydroxy
GA PCCA p-OH VA ChA 
eel (green) 2.46 ND 2.30 ND 0.56 
Yellow) 6.39 ND 6.36 ND 1.97 
Red) 2.46 ND 2.30 ND 2.98 
ulp (green) 3.09 2.28 60.31 ND ND 
Yellow) 2.57 2.87 2.53 ND ND 
Red) 3.13 ND 2.30 ND 2.82 
ril 4.97 16.15 29.16 ND 1.97 
ote:
A, gallic acid; PCCA, protocatechuic acid; p-HO, p-hydroxybenzoicacid; VA, vanill
cid; p-CA, p-coumaric acid; FA, ferulic acid; SNA, sinapic acid; ND, not detected.
ubola and Siriamornpun [16].uman Wellness 3 (2014) 117–126
eterocyclic prone C ring whereas non flavonoids phenolics con-
ains the heterogenous group of compounds. The non flavonoid
ompounds are further classified into phenolic acids, tannins,
tilbenes and ligans [14]. The polyphenols found in food can help
o protect oxidative damage by acting directly on reactive oxygen
pecies and induce endogenous defense system. Phytochemistry
nalysis of different plant parts of Momordica  species revealed
he presence of flavonoids, coumarins, anthroquinones, antho-
yanins and phenolic acids [15]. Various types of phenolic acids
uch as gallic acid, protocatechuic acid, gentisic acid, vanillic
cid, chlorogenic acid, tannic acid, caffeic acid, p-coumaric acid,
-hydroxybenzoic acid, gentisic acid, chlorogenic, syringic acid,
erulic and sinapic acid were identified in the pericarp, pulp and
eeds of M.  charantia  and M.  cochinchinensis  fruits. The content
f these compounds vary among different parts and species. M.
harantia is a rich source of gallic acid in all parts such as leaf
95.8 mg/L), stem (72.8 mg/L), green fruit (95.6 mg/L) and ripe
ruit (202 mg/L) [16]. According to Horax et al. [17], gentisic
cid is also the predominant phenolic acid in M.  charantia  where
t accounts maximum for 72.8 mg/100 g in immature green fruits
nd 214.6 mg/100 g in seeds but vanillic acid and t-cinnamic
cid were found lower in comparison to other phenolic acids.
n the case of wild M.  cochinchinensis, ferulic acid has been
eported as the predominant phenolic acid in pulp (92.94 mg/L)
ollowed by p-hydroxybenzoic acid in pulp (69.31 mg/L) and aril
29.16 mg/L). Vanillic acid has not been found in either parts of
his fruit. Table 3 shows the phenolic acid profiles of various fruit
ractions of M.  cochinchinensis.  The phenolic content of bitter
ourd fruits are determined by various factors such as the cul-
ivar, agronomic management, climatic factors, developmental
tage, harvesting time, storage conditions, and postharvest man-
gement. Most studies have investigated the functional activities
f bitter melon fruits, leaves and stems. It has been determined
hat the antioxidant capacity of bitter melon fruit is due to their
igh phenolic content [17]. Our previous report showed that the
resence of various phenolic acids in the leaves from varieties of
. charantia  and M.  dioica  [18]. Among them the wild leaves
ere reported to have higher phenolic acid composition and
ntioxidant activity than those of cultivated variety. Regarding
avonoids the presence of catechin, epicatechin, quercetin,
nchinensis fruits.
cinnamic acids (mg/g) Total mg GAE/g
CFA SyA p-CA FA SNA
ND ND ND ND ND 5.32
2.65 ND 4.14 11.32 7.38 40.2
2.97 ND ND ND ND 10.7
2.69 7.19 7.82 92.94 4.56 180.8
2.69 2.25 2.25 7 ND 22.2
3.2 3.81 2.24 6 ND 23.5
3.41 4.76 11.77 18 4.66 89.9
ic acid; ChA, chorogenic acid; VA, vanillic acid; CFA, caffic acid; SyA, syringic
G. Nagarani et al. / Food Science and H
Table 4
Carotenoid concentration of M. charantia and M. cochinchinensis seed mem-
brane (g/g fresh weight).
Carotenoid (g/g) M. cochinchinensis M.  charantia
α-Carotene 4.2 ND
β-Carotene 61.8 Trace
Lycopene 424.6 261
Zeaxanthin – Trace
Lutein 1.1 ND
Cryptoxanthin 1.9 Trace
Xanthophylls 9.9 ND
Total carotenoids 424.6 261
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saponins like goyasaponins I, II and III have been reportedD, not detected.
odriguez et al. [86]; Vuong et al. [87].
pigenin, myricetin, luteolin and kaempferol has been doc-
mented in different varieties on M.  charantia  and M.
ochinchinensis fruit fraction. The inner flesh and aril parts
ave higher flavonoid content than the other parts of the fruit
16,19]. Kaempferol, luteolin and apigenin were found only in
he wild species but not in M.  charantia  [20]. The increased
evel of antioxidant activity of green gac fruits might be caused
y the presence of flavonoid content. Rutin was reported in the
. tuberosa  and M.  charantia  whereas absent in M.  cochinchi-
ensis fruit. Our previous report on flavonoid composition of
omordica  leaves suggested that rutin was only found in M.
ioica and absent in the other two varieties of M.  charantia
18].
.2.  Carotenoids
The ripen fruits of Momordica  species contains a wide range
f carotenoids and are good sources of β-carotene [21], although
ild species have been explored for the highest content of
orotenoids. Especially, M.  cochinchinensis  is very popular for
ts high content of lycopene and β-carotene [22]. Table 4 sum-
arizes the carotenoids content that were found in the analyzed
pecies. The Momordica  fruit aril membrane and seed pericarp
ontain highly valuable sources of carotenoids [21]. They are
esponsible for the yellow, orange, and scarlet red colors of
ipen fruit of different species of bitter melon. The amount of
arotenoids in Momordica  fruit and seeds varied depend upon
he period of maturation. Lutein and -carotene are impor-
ant groups of carotenoids present in early and mature green
ruits. However, zeaxanthin and β-cryptoxanthin are less abun-
ant in early and mid-stage fruits than in mature fruits. A major
arotenoid, lycopene, a red carotenoid, is only accumulated in
he final stage when the pulp began to turn red [21]. Lycopene
ound to be high in aril and low in pulp but not detected in seeds
22]. On the other hand, the content of lutein was found to be rich
n peel (yellow) fractions, which was substantially higher than
ther fractions. However, the concentrations of each group of
orotenoids were lower than M.  cochinchinensis. Reports sug-
est that the intake of lutein or diets supplemented with rich
n lutein such as fruits and vegetables are important for the
revention of diseases like some cancers, eye diseases and car-
iovascular diseases [22,23]. In Vietnam, the seed membranes
i
s
puman Wellness 3 (2014) 117–126 121
f M.  cochinchinensis  are used to aid in the relief of dry eyes
ue to the presence of corotenoids [23].
.3.  Cucurbitane  type  triterpenoids
Cucurbitane triterpenoids are the main constituents of
ucurbitaceae family [24]. They exhibit a broad range of
otent biological activities namely hepatoprotective, cyto-
oxic, anti-inflammatory, cardiovascular, anti-diabetic and
ntiparasitic effects [24,25]. The terpenoids, also referred
s isoprenoids which is derived from five carbon isoprene
nits. The cucurbitacins are a typical group of cucurbitane
ype triterpenoids found in all plants and belonging to the
ucumber family (Cucurbitaceae) and have been reported
s the main chemical constituents of Momordica  species
rom different parts. Bitter melon contains several groups
f triterpenoids including charantin [26], kuguacins A-S
27], momordicine I, II and III [28] and karavilagenin A,
, C, D and E [29,30]. Hsu et al. [31] isolated the five new
erpenoids namely, cucurbita-6,22(E),24-trien-3β-ol-19,5β-
lide, 5β,19-epoxycucurbita-6,22(E),24-triene-3β,19-diol,
β-hydroxycucurbita-5(10),6,22(E),24-tetraen-19-al, 19-
imethoxycucurbita-5(10),6,22(E),24-tetraen-3β-ol and
9-nor-cucurbita-5(10),6,8,22(E),24-pentaen-3β-ol. Further-
ore, cucurbitane-type triterpene glycosides, charantagenins D
nd E are isolated from the fruit of M.  charantia  L. [32]. Hsiao
33] fractionated 15 cucurbitane-type triterpene glycosides
rom methanol extract of M.  charantia  fruit. Ma et al. [34]
solated two cucurbitane triterpenoids and bidesmoside triter-
enoid saponins from the seeds of M.  charantia. In addition,
eaves also considered as important sources of triterpenoids.
hang et al. [35] isolated seventeen cucurbitane-type triter-
enoids with six new compounds (23E)-3β,25-dihydroxy-7
-methoxycucurbita-5,23-dien-19-al, (23S*)-3 β-hydroxy-7
,23-dimethoxycucurbita-5,24-dien-19-al, (23R*)-23-O-
ethylmomordicine IV, (25§)-26-hydroxymomordicoside
, 25-oxo-27-normomordicoside L, and 25-O-
ethylkaravilagenin D. In addition, two new charantin
roup triterpenoids charantin A and charantin B were recently
solated from the leaves of M.  charantia  [36]. A number
f non-specific measures of saponin derivatives also exist
n Momordica  species. Saponins are steroid or triterpenoid
lycosides, common in a large number of plants and plant
roducts that are important in human and animal nutrition.
hese compounds have also been observed to kill protozoans
nd molluscs, to be antioxidants, to assist the digestion of
rotein and the uptake of vitamins and minerals in the gut, to
ause hypoglycaemia, and to act as antifungal and antiviral
gents [37]. Saponins are a group of high molecular-weight
ompounds in which the saccharide units of glycosides
ere linked with triterpene groups. charantosides (I–VIII),
omordicosides U, V, and W were some of the major saponins
dentified from M.  charantia  fruits [38,39]. Other types ofn the fresh fruit of Japanese M.  charantia  [40]. Triterpenoid
aponins such as momordicoside M, N, O, and L were generally
redominant in fresh green fruits of M.  charantia  [41]. The
1 and Human Wellness 3 (2014) 117–126
w
a
s
d
b
c
A
r
a
f
[
a
a
p
t
4
f
h
(
p
o
t
p
s
p
2
α
-
-
5
s
5
t
o
M
b
g
u
t
p
i
i
s
h
i
m
1
S
b
b
p
[
t
t
a22 G. Nagarani et al. / Food Science 
ild species such as M.  balsamina  and M.  cochinchinensis
re also major sources of triterpenoids. M.  balsamina  contains
everal cucurbitane-type triterpinoids which are isolated from
ifferent parts including balsaminapentaol, balsaminol A,
alsaminol B, cucurbalsaminol A, cucurbalsaminol B [42]. M.
ochinchinensis  contained five saponins triterpenoids namely
, B, C, D and E [43]. The cucurbitane-type triterpenoids were
eported for several medicinal properties such as hypoglycemic,
ntiproliferative activities and also used for the treatment of
ree radical and reactive oxygen species mediated diseases
30]. In addition, these compounds were reported as partial
gonist/antagonist for estrogen receptors such as ER  and ER
nd were used for the management of estrogen related health
roblems [44]. Some of the newly identified triterpenoids with
heir structure are shown in Fig. 2.
.4.  Phytosterols
Sterols cannot be synthesized by humans and are absorbed
rom the diet in small but significant amounts. Plant sterols
ave proved to lower serum total and low density lipoproteins
LDL)-cholesterol concentrations, so they have been incor-
orated into functional foods. Sterols are minor components
f human dietary lipids and comprise the major portion of
he unsaponifiable fraction of most edible fats and oils. Nine
redominant phytosterols have been identified in Momordica
pecies namely, decortinone, decortinol, clerosterol, ergosterol
eroxide, 3 β-hydroxy-(22E,24R)-ergosta-5,8,22-trien-7-one,
2-diene-3β,7α-diol, 5 α,6 α-epoxy-(22E,24R)-ergosta-8, 6
-epoxy-(22E,24R)-ergosta-8,22-diene-3 β,7 β-diol, 5 α,6 α
epoxy-(22E,24R)-ergosta8,22-diene-3β,7α-diol, and 5 α,6 α
epoxy-3β-hydroxy-(22E,24R)-ergosta-8,22-dien-7-one [45].
.  Effect  of  physiological  bioactivities  of  Momordica
pecies on  human  health
.1.  Anti-diabetic  activity
Diabetes poses a major challenge and the economic pressure
o the world population, leading to increasing interest in the use
f traditional remedies for the treatment of diabetes mellitus.
omordica species are well known for the treatment of dia-
etes from ancient times and nowadays the tablet forms of bitter
ourd are also available in the market. Momordica  species are
sed for the treatment of both Types I and II diabetes. Insulin is
he mainstay for patients with type 1 diabetes. Recently, several
roteins were isolated from M.  charantia  which were involved
n the insulin signaling pathway. Isolated compounds such as
nsulin-like peptide (plant (p)-insulin), charantin, vicine, glyco-
ides, karavilosides, fruit and seed extract, juices and powders
ave demonstrated potential effects in lowering blood sugar by
ncreasing glucose uptake and glycogen synthesis in the liver,
uscles, and fat cells and activating insulin receptor substrate
 (IRS1) in skeletal muscle by tyrosine phosphorylation [46].
ome other reports stated that the hypoglycemic effects might
e due to the significant increase in   cell number, glucose uptake
y skeletal muscle and adipose tissue, and activation of AMPK
t
i
p
tFig. 2. Structure of novel triterpenoids from Momordica species.
athway that stimulates the insulin secretion [47]. Hazarika et al.
48] studied the docking mechanism by block the active site of
he glycogen synthase kinase-3 (GSK-3) protein with known
hree anti-diabetic compounds namely, charantin, momordenol
nd momordicilin. GSK-3 is one of the negative regulators in
he hormonal control of glucose homeostasis which are involved
n the carbohydrate metabolism through the mechanism of
hosphorylation and inactivation of the enzyme glycogen syn-
hase. The novel IR-binding protein (Trypsin inhibitor) was
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solated from aqueous extract of M.  charantia  seeds, which
owered blood sugar levels by regulating the insulin signaling
athway in muscles and adipose tissues and stimulating the IR-
ownstream pathway [49]. M.  charantia  extract also considered
s an herbal remedy for type-II diabetes, contains a specific
1β-hydroxysteroid dehydrogenase type 1 inhibitor, responsi-
le for reducing the PPARA gene expression [46]. Folk wisdom
howed that Momordica  species helps to prevent or counteract
ype II diabetes, improves glucose tolerance and suppress post-
randial hyperglycemia in rats [50]. Oxidative stress is also one
f the causative mechanisms for diabetes. M.  charantia  fruit
uice is reported to restore antioxidant enzymes like superox-
de dismutase and catalase in diabetic patients to the normal
evel [51]. Treatment of alloxan induced diabetic rats with bitter
elon prevented the death of -cells by decreasing the oxida-
ive stress due to the presence of vitamin C (an anti-oxidant).
eeding saponin-rich fraction of M.  cymbalaria  over a period of
ne month to streptozotocin-induced Type II diabetic mice leads
o increased insulin secretion, hepatic glycogen synthesis and
ttenuation of hyper insulinemia. Also the treated groups showed
n increase in the number of pancreatic islets and β-cells in the
ancreas [52]. Treatment with the fruit extract of M.  tuberosa
nd seed extract of M.  dioica  has been shown to decrease blood
lucose level in diabetic rats with simultaneous reduction in
erum cholesterol, triglycerides and lipoproteins [53,54]. With
espect to the clinical trials, 12-weeks treatment with bitter gourd
ablet was conducted in different groups of patients after nor-
al meals. The study showed that regular consumption of these
ablets associated with positive effects in glucose, cholesterol,
DL, LDL, triglyceride levels and had beneficial effects on glu-
ose tolerance [55]. Furthermore, nanoparticles of extract of
. charantia  and its adsorption on polyethylene glycol (PEG)
icrospheres are considered as an alternative treatment of dia-
etes [56]. Considering all these facts, it can be concluded that
omordica  has potential anti-diabetic properties, which may
uggest the inclusion of this plant in anti-diabetic regimens.
owever, further studies in details are warranted to explore
he mechanistic and therapeutic potential of Momordica  for
ecreasing serum glucose concentration in combination with
he active phytochemical substances.
.2.  Anti-cancer  activity
In the last few decades, a number of preliminary stud-
es have been carried out to reveal the anti-cancer activity of
omordica  sp. There are many significant evidences suggest-
ng links between diets rich in bitter melon and lower risk of
ymphoid leukemia, lymphoma, choriocarcinoma, melanoma,
reast cancer, skin tumor, prostatic cancer, squamous carci-
oma of the tongue and larynx, human bladder carcinomas and
odgkin’s disease [57]. There are some epidemiological evi-
ence stating that intake of bitter melon are inversely related
o the incidence of cancer. Methanol extract of M.  charantia
as shown to inhibit the growth of four human cancer cell lines,
one-1 nasopharyngeal carcinoma cells, AGS gastric adenocar-
inoma cells, HCT-116 colorectal carcinoma cells, and CL1-0
ung adenocarcinoma cells. M.  charantia  induces cell death by
o
i
i
auman Wellness 3 (2014) 117–126 123
ctivating the caspase-3 enzyme and increase the level of apop-
ogenic protein and the expression of Bax gene, which induces
NA fragmentation and nuclear condensation [58]. Treatment
f fractionated seed extract of M.  charantia  in human myeloid
L60 cells induced the differentiation and can be used as ther-
py for leukemia [59]. Pitchakarn et al. [60] reported that fresh
itter melon leaf extract significantly decreased the gene expres-
ion of MMP-2 and MMP-9 in a breast cancer cell line. It
as also been found that these extract could increase them
NA level of TIMP-2, known to have inhibitory effects on the
ctivity of MMP-2. Most attention to date has focused on sev-
ral phytoconstituents of Momordica  including triterpenoids,
uguacin J, -momorcharin and MAP 30 protein. Fang et al.
61] reported the inhibiting property of MAP 30 protein iso-
ated from seeds of M.  charantia  against the growth of Hep
2 leukemia cells. Moreover, other proteins from M.  charantia
eeds were reported to inhibit melanoma proliferation. Xiong
t al. [62] isolated a novel ribosome-inactivating protein called
-momorcharin and -momorcharin from the mature seeds of
. charantia  which efficiently inhibits the growth of prostate
ancer. Manoharan et al. [63] described the mechanisms of this
hytochemical in different cancer cell lines, -momorcharin and
-momorcharin increased the cell death specifically in cancer
ell lines by increasing the caspase-3 and 9 activities, releas-
ng cytochrome c and elevating calcium level. Recently, Weng
t al. [44] isolated a novel cucurbitane-type triterpenoid (3β, 7β-
ihydroxy-25-methoxycucurbita-5, 23-diene-19-al) from wild
itter gourd that induces apoptotic death in breast cancer cells.
amalhete et al. [64] proved that some novel cucurbitacins, bal-
aminagenin B, balsaminoside A and the known cucurbitacin
aravelagenin C, together with some new mono or diacylated
erivatives of karavelagenin C from aerial parts of M.  balsamina
trongly inhibited the human MDR1 gene transfected to mouse
ymphoma cells. The seed extracts of M.  cochinchinensis  have
een reported as inhibitors for breast cancer against ZR-75-30
reast cancer cells [65].
.3.  Antioxidant  activity
Oxidative stress is implicated in the etiology of many dis-
ases such as dyslipidaemia, atherosclerosis, obesity, Type II
iabetes, arthritis, cancer, cardio vascular diseases and neurode-
enerative diseases. It is a condition of increased production
f free radicals and other reactive oxygen species and decreased
ntioxidative defenses [66]. Various extracts of bitter gourd have
otential antioxidant activity which might play an important
ole in diabetic-related enzymes and individuals with neuroin-
ammation and liver diseases. Nerurkar et al. [67] reported
hat the administration of bitter melon fruit extract significantly
educed the neurodegenerative diseases as its role as antioxi-
ant to reveal a mechanism for its neuroinflammation action.
ucurbitane-type triterpene glycoside 1 and 3 isolated from
tems and fruits of M.  charantia  significantly inhibit the effect
n Xanthine oxidase activity which is the key enzyme for the
nduction hyperuricemia and gout [68]. Antioxidant compounds
n bitter gourd pulp and seed powders showed potential natural
ntioxidant activity to inhibit the lipid peroxidation in sunflower
1 and H
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il [69]. Moreover, the antioxidant activity of butanol fraction
f M.  charantia  was determined in in  vitro  and a cellular sys-
em and the extract effectively ameliorated oxidative damage
nduced by ONOO- [70]. The potential antioxidant activity of M.
alsamina has already been reported and its antioxidant compo-
ents are polyphenols, inhibiting 5-lipo-oxygenase enzyme that
s responsible for inflammation [71].
As previously stated, bitter gourd was generally consumed
fter cooking, so it is important to analyze the effect of heat
reatment on bitter gourds. Phan-Thi and Wache [72] studied the
ffect of heat treatment on lycopene concentration and antioxi-
ant ability. They found that moderate heating transferred all
rans-isomers to cis-isomers leading to increased antioxidant
ctivity. In the case of M.  charantia, blanching considerably
ecrease the phenolic content and antioxidant activity which
enoted that thermal treatment is more suitable for wild species
ompared to commercial variety [73].
.4.  Anti-microbial  activity
Various broad-spectrum anti-microbial components have
een isolated from Momordica  species. M.  charantia  leaf extract
nhibits Escherichia  coli, Klebsiella  pneumonia  and Bacillus
ubtilis with a maximum inhibitory activity at a concentration of
0% (V/V). Purified triterpenoid ester from M.  cochinchinensis
eaves was proved to inhibit Trigrophyton  mentagrophytes  and
andida albicans  [74]. MAP-30 and type-I ribosome inactivat-
ng protein from bitter melon reported to have anti-HIV activity
75]. Fruit pulp of M.  balsamina  was found to be effective against
IV-1 and significantly increased the CD4 count within the first
wo weeks of treatment when compared to the untreated mice
76]. Adesina et al. [77] reported that application of bitter melon
eaf powder at the concentration of 2 g greatly reduced Calloso-
ruchus  maculates  in stored cowpea seeds. Methanol extract of
itter melon leaves exhibited strong oviposition deterrent activ-
ty against Liriomyza  trifolii  females on the host plant leaf when
t was dipped in the methanol extract at a concentration of 1 mg
f fresh leaf equivalent/mL [41].
.5.  Other  medicinal  effects
Momordica-supplemented foods are considered as good
ources of hepatoprotective substances, which can help to pro-
ect liver damage by restoring liver markers and preventing the
ipid peroxidation reaction [78]. Lii et al. [79] reported that wild
itter melon fruit pulp significantly inhibited lipopolysaccaride-
nduced inflammatory response in rats. Momordica  has potential
nti-fertility activity in both male and female mice. It induced
rregular estrous cycles and suppressed the release of ova and
aused highly significant post-coital anti-implantation effect
n early stage of pregnant [80]. The glycoprotein, - and
-momorcharins isolated from M.  charantia  seeds induced
he testicular degeneration in male animals and the effect
as reversible within a predictable time frame of 8 weeks
fter discontinuation of the treatment [81]. Analgesic anduman Wellness 3 (2014) 117–126
europrotective activity were observed in M.  dioica  fruit and
. charantia  fruit juice [82,83].
.  Conclusions
Momordica  species may be considered as a nutritious veg-
table and can play a role in health improving attributes of
heir wide range of functional components. The green fruits,
eaves and stems were rich sources of triterpenoids, carotenoids,
henolics that could potentially be used as antioxidants in
utraceutical, pharmaceutical, and cosmetic industries. Com-
are to the known common variety, the wild species offers more
otential phytoconstituents for improving the human health.
he regular consumption of these wild bitter gourds associated
ith the reduced risk of several chronic diseases mainly dia-
etes for cost effective treatment for rural communities. The
ealth promoting properties of common cultivated variety have
een demonstrated in both in  vitro  and in  vivo  studies. How-
ver, studies on wild species remain sparse. Finally, the review
ndertaken here generated many suggestions concerning the
utritional value, bioactive components, medicinal, nutraceu-
ical and functional food properties of these plant resources may
erve as a foundation for future investigations/interventions.
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